Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$22.74
+0.76%
Mkt Cap $1.68B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
Implied Upside
+75.9%
Consensus $40.00 vs current $22.74
NASDAQ·Healthcare·Biotechnology
$22.74
+0.76%
Mkt Cap $1.68B
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
+75.9%
Consensus $40.00 vs current $22.74